<DOC>
	<DOCNO>NCT01060722</DOCNO>
	<brief_summary>This study aim examine safety , tolerability pharmacokinetics long-lasting Human Growth Hormone ( MOD-4023 ) healthy volunteer single subcutaneous injection escalate dos .</brief_summary>
	<brief_title>MOD-4023 Study Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male volunteer age 1845 ( inclusive ) year . Body Mass Index ( BMI ) 19 30 kg/m2 ( inclusive ) weigh least 55 Kg . Nonsmoking ( declaration ) period least 6 month prior screen visit . Subjects generally good health opinion investigator determine medical history , vital sign physical examination . Blood pressure heart rate within normal limit ( blood pressure : systolic 90140mmHg ; diastolic 5090 mmHg , heart rate 40100 beat per minute ) . Electrocardiogram ( ECG ) clinically significant abnormality record screen visit ( 21 day dose ) dose day ( drug administration ) : PR interval within 120 200 m , QRS interval &lt; 120 m , QTc interval â‰¤ 440 m . Negative HIV , hepatitis B hepatitis C serology test screen No clinically significant abnormality complete blood count ( CBC ) , prothrombin time ( PT , INR ) , activate partial thromboplastin time ( aPTT ) , chemistry lab test ( liver renal function ) urinalysis screen . No history alcohol drug abuse . Negative urine DoA screen admission . Negative breath alcohol admission . Subjects must agree use medically accept form contraception dose day 12 week drug administration . Subjects must able understand requirement study must willing comply requirement study provide write informed consent participate study . History significant neurological ( include history seizure EEG abnormality ) , renal , cardiovascular ( include know structural cardiac abnormality hypertension ) , respiratory ( asthma ) , endocrinological , gastrointestinal , hematopoietic disease , neoplasm , psychological ( marked anxiety , tension agitation ) clinically significant medical disorder , investigator 's judgment contraindicate administration study medication . Diabetes . Known allergy drug . Adherence ( whatever reason ) abnormal diet 4 week prior study , subject recent significant change body weight . Use prescription overthecounter ( OTC ) medication , include vitamin herbal dietary supplement within 14 day prior dose . Paracetamol symptomatic relief pain allow 24 hour prior study drug administration . Subjects receive vaccine within 4 week prior study drug administration . Subjects donate blood three month receive blood plasma derivative six month precede study drug administration . Participation another clinical trial drug within 3 month prior dose ( calculate previous study 's last dosing date ) . Subjects inability communicate well investigator CRC staff ( i.e. , language problem , poor mental development impair cerebral function ) . Subjects difficulty fast consume standard meal provide . Subjects acute medical situation ( e.g . acute infection ) within 48 hour study start , consider significance Principal Investigator . Subjects noncooperative unwilling sign consent form .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Healthy Male Volunteers</keyword>
</DOC>